Marine Biotechnology Global Market Report 2026

Marine biotechnology is a scientific field that involves harnessing marine organisms, their genetic material, and related bioactive substances for diverse applications. This branch of science encompasses the study and manipulation of marine organisms, including plants, animals, and microorganisms, with the aim of developing products, processes, and technologies applicable in industries such as cosmetics, nutritional supplements, pharmaceuticals, and more.

The primary categories of marine biotechnological products include bioactive substances and biomaterials. Bioactive substances encompass a broad spectrum of biological, pharmacological, and nutraceutical activities, known for their beneficial effects on nutrition and health. Sources of these substances include corals and sponges, algae, marine viruses, marine fungi, and others. Various technologies are employed, such as the isolation and cultivation of microorganisms and culture-independent techniques. These technologies find applications in diverse fields, including aquaculture and food products, environmental and human health, and drug discovery. End-users of marine biotechnological products span industries such as medical and pharmaceutical, the food industry, the cosmetic industry, the chemical industry, and more.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Tariffs are impacting the marine biotechnology market by increasing the cost of laboratory equipment, specialized research instruments, biological processing tools, and certain marine derived raw materials sourced internationally, thereby raising research and production expenditure. Applications in pharmaceuticals, cosmetics, food, and biotechnology sectors across regions such as North America, Europe, and Asia Pacific are particularly affected. However, tariffs also encourage regional research investments, domestic biotechnology development, and localized production initiatives. Overall, tariffs introduce financial challenges but simultaneously foster regional capability expansion, innovation acceleration, and stronger marine biotechnology development ecosystems worldwide.

The marine biotechnology market research report is one of a series of new reports from The Business Research Company that provides marine biotechnology market statistics, including marine biotechnology industry global market size, regional shares, competitors with a marine biotechnology market share, detailed marine biotechnology market segments, market trends and opportunities, and any further data you may need to thrive in the marine biotechnology industry. This marine biotechnology market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The marine biotechnology market size has grown strongly in recent years. It will grow from $6.6 billion in 2025 to $7.1 billion in 2026 at a compound annual growth rate (CAGR) of 7.5%. The growth in the historic period can be attributed to growing scientific interest in marine organisms, increasing demand for natural bioactive compounds, expansion of marine research initiatives, rising pharmaceutical and cosmetic applications, development of marine resource utilization technologies.

The marine biotechnology market size is expected to see strong growth in the next few years. It will grow to $9.64 billion in 2030 at a compound annual growth rate (CAGR) of 8.0%. The growth in the forecast period can be attributed to increasing investment in marine biotech R&D, rising focus on advanced drug discovery from marine sources, growing nutraceutical and cosmetic industry demand, expanding environmental and health biotechnology applications, stronger emphasis on sustainable marine resource exploitation. Major trends in the forecast period include increasing exploration of marine derived bioactive compounds, rising focus on marine based pharmaceutical development, growing utilization of marine resources in nutraceutical production, expansion of marine biotechnology applications in healthcare, increasing emphasis on sustainable marine biological research.

The increase in biofuel production is anticipated to support the growth of the marine biotechnology market in the coming years. Biofuel is a form of renewable energy produced from organic materials such as plants, crops, and microorganisms through biological processes that generate fuels suitable for combustion. Marine biotechnology plays a key role in advancing biofuel development by providing environmentally friendly alternatives to meet the rising demand for renewable energy sources. For example, in October 2025, data from the U.S. Energy Information Administration (EIA), a US-based independent statistical agency, indicated that biofuel output in the United States weakened in 2024, with production capacity increasing by only 3% from early 2024 to early 2025. As a result, the growth in biofuel production is contributing to the expansion of the marine biotechnology market.

Product innovations are a significant trend gaining traction in the marine biotechnology market. Major companies in this sector are concentrating on developing new products to enhance their market position. For example, in September 2024, Hi-Q Marine Biotech International Ltd, a Taiwan-based biotechnology firm, introduced OliFuco RE, a product designed to manage sarcopenia and promote tissue regeneration, specifically targeting age-related muscle loss. OliFuco RE is a low molecular weight fucoidan powder sourced from brown seaweed, known for its bioactive properties. It facilitates muscle regeneration and notably improves muscle mass and strength in older adults. This scientifically validated formulation presents a promising solution for addressing sarcopenia and represents a potential breakthrough in nutraceuticals focused on muscle preservation and regeneration.

In September 2024, Blue Future Holding, a Norway-based investment management company, acquired complete ownership of GreenFox Marine for an undisclosed sum. This acquisition bolsters Blue Future Holding's strategy to broaden its portfolio in the aquaculture sector and aligns with its commitment to investing in sustainable seafood solutions. GreenFox Marine, also based in Norway, specializes in developing advanced technologies for the aquaculture industry, particularly in automated sex sorting of salmon.

Major companies operating in the marine biotechnology market report are Cyanotech Corporation, CP Kelco US Inc., PharmaMar S.A., Nofima A.S., NovaMatrix, GlycoMar Ltd., SEPPIC Inc., Marinova Pty. Ltd., Prolume Ltd., Aker BioMarine Antarctic AS, Tequesta Bioventures LLC, Marinomed Biotech AG, AstaReal Co. Ltd., Euglena Co. Ltd., Earthrise Nutritionals LLC, Bluebiotech International GmbH, Nutrex Hawai Inc., Kepley Biosystems Incorporated, Finless Foods Inc., Jellagen Pty Ltd, KnipBio Inc.

Europe was the largest region in the marine biotechnology market in 2025. The regions covered in the marine biotechnology market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the marine biotechnology market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The marine biotechnology market includes revenues earned by entities by providing services such as bioprospecting and bioactive compound discovery, genetic analysis and genomic studies, bioprocessing, fermentation, pharmaceutical discovery, and materials technology. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Marine Biotechnology Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses marine biotechnology market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on end user analysis.
• Benchmark performance against key competitors based on market share, innovation, and brand strength.
• Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for marine biotechnology ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The marine biotechnology market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
• The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
• The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
• The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
• The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
• The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

• Markets Covered:1) By Type: Bio Active Substance; Bio Materials
• 2) By Source: Corals And Sponges; Algae; Marine Viruses; Marine Fungi; Other Sources
• 3) By Technology: Isolation And Cultivation of Microorganisms; Culture-Independent Techniques
• 4) By Application: Aquaculture And Food Products; Environment And Human Health; Drug Discovery
• 5) By End User: Medical And Pharmaceutical; Food Industry; Cosmetic Industry; Chemical Industry; Other End Users
• Subsegments:
• 1) By Bio Active Substance: Marine-Derived Pharmaceuticals; Nutraceuticals; Enzymes
• 2) By Bio Materials: Biopolymers; Bio-Composite Materials; Bio-Based Coatings
• Companies Mentioned: Cyanotech Corporation; CP Kelco US Inc.; PharmaMar S.A.; Nofima A.S.; NovaMatrix; GlycoMar Ltd.; SEPPIC Inc.; Marinova Pty. Ltd.; Prolume Ltd.; Aker BioMarine Antarctic AS; Tequesta Bioventures LLC; Marinomed Biotech AG; AstaReal Co. Ltd.; Euglena Co. Ltd.; Earthrise Nutritionals LLC; Bluebiotech International GmbH; Nutrex Hawai Inc.; Kepley Biosystems Incorporated; Finless Foods Inc.; Jellagen Pty Ltd; KnipBio Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: Word, PDF or Interactive Report
• + Excel Dashboard
• Added Benefits
• Bi-Annual Data Update
• Customisation
• Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.